22 results
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... Action #Asthma #Medications ... #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
Treatment Algorithm for Pulmonary Hypertension

#Pulmonary #Hypertension #PAH #Treatment #Management #Algorithm #Medications
Treatment Algorithm ... for Pulmonary Hypertension ... #Pulmonary # ... #Management #Algorithm ... #Medications
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary ... LAMA #LABA #ICS #Guidelines
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... #prescribing #Pulmonary ... #Algorithm #treatment ... #pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology # ... treatment #medications
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #StepUp #Treatment ... #Algorithm #Guidelines
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Therapy #regimens #medications ... #pharmacology # ... IDSA #Guidelines ... #Treatment
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... Symptomatic treatment ... systemicsclerosis #SSc #pulmonary ... #indications #management ... #treatment #algorithm
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... for the Management ... with ‘treatment ... #Pharmacology # ... Personality #Disorder #Medications
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... getting patients on medication ... both of these medications ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment